SAN DIEGO--(BUSINESS WIRE)--Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced that Jay Lichter, president and chief executive officer, has recently made a presentation to the investment community at the Informed Investors Biotech/Pharma/Healthcare On-line Forum on Tuesday, September 18, 2007 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time).
